Fulgent Genetics Inc logo

FLGT - Fulgent Genetics Inc Share Price

$92.25 0.3  0.4%

Last Trade - 30/07/21

Mid Cap
Market Cap £1.91bn
Enterprise Value £1.63bn
Revenue £554.0m
Position in Universe 2009th / 7015
Unlock FLGT Revenue
Relative Strength (%)
1m -6.18%
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -51.6%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
9.58 18.3 18.7 21.4 32.5 421.7 830 340.8 +113.2%
+37.7 -73.1
Balance Sheet
FINANCIAL BRIEF: : For the three months ended 31 March 2021, FulgentGenetics Inc revenues increased from $7.8M to $359.4M. Netincome totaled $200.7M vs. loss of $2M. Revenues reflectUnited States segment increase from $5.6M to $357.5M, OtherCountries segment increase of 27% to $1.9M. Net Incomereflects Equity loss in investee decrease from $249K(losses) to $0K, Interest income and other income increaseof 17% to $282K (income).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Latest News & Insights for FLGT
Graphical History


FLGT Revenue Unlock FLGT Revenue

Net Income

FLGT Net Income Unlock FLGT Revenue

Normalised EPS

FLGT Normalised EPS Unlock FLGT Revenue

PE Ratio Range

FLGT PE Ratio Range Unlock FLGT Revenue

Dividend Yield Range

FLGT Dividend Yield Range Unlock FLGT Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
Net Profit
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
FLGT EPS Forecasts Unlock FLGT Revenue
Profile Summary

Fulgent Genetics, Inc. is a technology company. The Company offers genetic testing to provide physicians with clinically actionable diagnostic information to improve quality of patient care. The Company has developed a technology platform that integrates data comparison and suppression algorithms, adaptive learning software, advanced genetic diagnostics tools and integrated laboratory processes. As of December 31, 2015, the Company's test menu includes approximately 18,000 single-gene tests and over 200 pre-established, multi-gene, disease-specific panels that collectively test for approximately 7,500 genetic conditions, including various cancers, cardiovascular diseases and neurological disorders. The Company's gene probes are specifically engineered to generate genetic data that is optimized for its software, which enables to rapidly incorporate new genes into its test menu, develop new panels of disease-specific tests and customize tests for its customers.

Last Annual December 31st, 2020
Last Interim March 31st, 2021
Incorporated May 13, 2016
Public Since September 28, 2016
No. of Shareholders: 9
No. of Employees: 429
Sector Healthcare
Industry Healthcare Equipment & Supplies
Index Nasdaq Composite , S&P 600 Small Cap , S&P Composite 1500 ,
Exchange NASDAQ Global Market
Shares in Issue 29,005,206
Free Float (0.0%)
Eligible for
FLGT Share Price Performance
Share Price
Bid - Ask
Low - High
Day's Change
Avg Volume
Open - Close
Range (12m)
Latest News for FLGT
Upcoming Events for FLGT
Monday 9th August, 2021
Q2 2021 Fulgent Genetics Inc Earnings Release
Monday 9th August, 2021
Q2 2021 Fulgent Genetics Inc Earnings Call
Monday 8th November, 2021 Estimate
Q3 2021 Fulgent Genetics Inc Earnings Release
Frequently Asked Questions for Fulgent Genetics Inc
What is the Fulgent Genetics Inc share price?

As of 30/07/21, shares in Fulgent Genetics Inc are trading at $92.25, giving the company a market capitalisation of £1.91bn. This share price information is delayed by 15 minutes.

How has the Fulgent Genetics Inc share price performed this year?

Shares in Fulgent Genetics Inc are currently trading at $92.25 and the price has moved by 0.258k% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Fulgent Genetics Inc price has moved by 0.164k% over the past year.

What are the analyst and broker recommendations for Fulgent Genetics Inc?

Of the analysts with advisory recommendations for Fulgent Genetics Inc, there are there are currently 1 "buy" , 1 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Fulgent Genetics Inc is Hold. You can view the full broker recommendation list by unlocking its StockReport.

When will Fulgent Genetics Inc next release its financial results?

Fulgent Genetics Inc is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2022-03-31
What is the Fulgent Genetics Inc dividend yield?

Fulgent Genetics Inc does not currently pay a dividend.

Does Fulgent Genetics Inc pay a dividend?

Fulgent Genetics Inc does not currently pay a dividend.

When does Fulgent Genetics Inc next pay dividends?

Fulgent Genetics Inc does not currently pay a dividend.

How do I buy Fulgent Genetics Inc shares?

To buy shares in Fulgent Genetics Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Fulgent Genetics Inc?

Shares in Fulgent Genetics Inc are currently trading at $92.25, giving the company a market capitalisation of £1.91bn.

Where are Fulgent Genetics Inc shares listed? Where are Fulgent Genetics Inc shares listed?

Here are the trading details for Fulgent Genetics Inc:

Country of listing: United States
Exchange: NMQ
Ticker Symbol: FLGT
What kind of share is Fulgent Genetics Inc?

Based on an overall assessment of its quality, value and momentum, Fulgent Genetics Inc is currently classified as a Super Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Fulgent Genetics Inc share price forecast 2021?

Shares in Fulgent Genetics Inc are currently priced at $92.25. At that level they are trading at 5.35% premium to the analyst consensus target price of 0.00.

Analysts covering Fulgent Genetics Inc currently have a consensus Earnings Per Share (EPS) forecast of 12.454 for the next financial year.

How can I tell whether the Fulgent Genetics Inc share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Fulgent Genetics Inc. Over the past six months, the relative strength of its shares against the market has been -28.66%. At the current price of $92.25, shares in Fulgent Genetics Inc are trading at 19.59% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Fulgent Genetics Inc PE Ratio?

The Fulgent Genetics Inc PE ratio based on its reported earnings over the past 12 months is 6.14. The shares are currently trading at $92.25.

The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.

The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.

Who are the key directors of Fulgent Genetics Inc?

Fulgent Genetics Inc's management team is headed by:

Ming Hsieh - CHM
Paul Kim - CFO
Han Lin Gao - CSO
John Bolger - IND
Yun Yen - IND
Linda Marsh - IND
Jian Xie - COO
Who are the major shareholders of Fulgent Genetics Inc?

Here are the top five shareholders of Fulgent Genetics Inc based on the size of their shareholding:

Hsieh (Ming) Individual Investor
Percentage owned: 27.23% (7.90m shares)
BlackRock Institutional Trust Company, N.A. Investment Advisor
Percentage owned: 8.38% (2.43m shares)
iShares Core S&P Small-Cap ETF Mutual Fund
Percentage owned: 4.12% (1.20m shares)
Xi Long USA, Inc. Corporation
Percentage owned: 3.68% (1.07m shares)
The Vanguard Group, Inc. Investment Advisor/Hedge Fund
Percentage owned: 3.63% (1.05m shares)
Similar to FLGT
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.